Target intelligence / Profile preview

Keratin 18 pseudogene 40 (KRT18P40)

Target
KRT18P40
Molecular classification
Pseudogene, Other
01

Overview

Keratin 18 pseudogene 40 (KRT18P40) is a processed pseudogene related to the *keratin 18* (KRT18) gene, belonging to the large keratin gene family, which encodes the type I intermediate filament protein Keratin 18. Pseudogenes such as KRT18P40 are non-coding, non-functional genetic elements that originate from retrotransposition or gene duplication events, and they do not produce functional proteins[3][4][5]. The human genome contains a high number of processed pseudogenes for keratin 8 and keratin 18, dispersed throughout various chromosomes; specifically, there are at least 77 processed pseudogenes for keratin 18[3][5]. None of these processed pseudogenes contain an intact reading frame or are expressed as functional proteins[4][5]. Therefore, KRT18P40 is not a therapeutic target, does not have biological function, disease role, drug interactions, or clinical relevance. Its presence is only of interest in the context of gene family evolution, molecular genetics, and genomics research. Keratin 18 itself (the functional gene, not the pseudogene) is a well-established biomarker and regulator in certain cancers and epithelial cell biology[1]. This information is not applicable to KRT18P40, which is a non-functional pseudogene and not involved in these biological processes or disease mechanisms. In summary: KRT18P40 is a non-coding pseudogene and not a protein-coding therapeutic target, nor does it have biological, clinical, or pharmacological relevance[4][5].

Beyond the preview

Go deeper on Keratin 18 pseudogene 40 (KRT18P40).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keratin 18 pseudogene 40 (KRT18P40).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call